Parenteral Drugs (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Parenteral Drugs (India) Ltd. on BSE

Search Inside the pdf :

23 Jan 2025

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by …

BSE India

According to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and in accordance with the requirements of Sub clause 16(k) of Para A of part A of Schedule III of Listing Regulations, we wish to inform you that the Hon''ble NCLT, Mumbai has approved the resolution plan in the matter of the Corporate Debtor namely Parenteral Drugs(India) Ltd. vide their order dated 16.01.2025 as enclosed hereunder

pdf

Parenteral Drugs (India) Ltd.

22 Jan 2025

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by …

BSE India

According to Regulation 30 of SEBI(Listing Obligation and Disclosure Requirements) Requirements, 2015 (Listing Regulations) and in accordance with the requirements of Sub- clause 16(k) of Para A of part A of Schedule III of Listing Regulations, we wish to inform you that the Hon''ble NCLT, Mumbai has approved the resolution plan in the matter of the Corporate Debtor namely parenteral Drugs (india) Ltd. vide their order dated 16.01.2025.

pdf

Parenteral Drugs (India) Ltd.

07 Dec 2024

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee …

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, we would like to inform that the 22nd CoC of Parenteral Drugs (India) Limited was held on Thursday, 05.12.2024 at 5:30 p.m.

pdf

Parenteral Drugs (India) Ltd.

05 Dec 2024

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee …

BSE India

Pursuant to Regulation 30 SEBI (LODR) Regulations, 2015 and in accordance with the requirements of Schedule III of the Listing Regulations, we wish to inform you that the 19th CoC meeting of Parenteral Drugs (India) Limited is scheduled to be held on Thursday, 05.12.2024 at 5:30 p.m.

pdf

Parenteral Drugs (India) Ltd.

10 Sep 2024

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee …

BSE India

Pursuant to Regulation 30 of SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and in accordance with the requirements of sub-clause 16(g) of Para A of Part A of Schedule III of Listing Regulations, we would like to inform that the Twentieth Meeting of Committee of Creditors (CoC) of Parenteral Drugs (India) Limited, the Corporate Debtor was held on Monday, 09th September, 2024 at 05:30 P.M.

pdf

Parenteral Drugs (India) Ltd.

13 Aug 2024

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee …

BSE India

Pursuant to Regulation 30 of SEBI(Listing Obligation and Disclosure Requirements), 2015(Listing Regulations) and in accordance with the requirements of the sub-clause 16(g) of Para A of Part A of Schedule III of Listing Regulations, we would like to inform that the Nineteenth Meeting of Committee of Creditors ("CoC") of Parental Drugs(India) Limited, the Corporate Debtor was held on Monday 12th August, 2024 at 2:30 P.M.

pdf

Parenteral Drugs (India) Ltd.

10 Aug 2024

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and in accordance with the requirements of sub -clause 16(g) of Para A of Part A of Schedule III of Listing Regulations, we wish to inform you that the Nineteenth meeting of Committee of Creditors ("CoC"), of Parenteral Drugs (India) Limited, the Corporate Debtor is Scheduled to be held on Monday, 12th August, 2024 at 02:30 P.M.

pdf

Parenteral Drugs (India) Ltd.

10 Aug 2024

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 (Listing Regulations) and in accordance with the requirements of sub-clause16(g) of Para A of Part A of Schedule III of Listing Regulations, we would like to inform that the Eighteenth Meeting of Committee of Creditors ("CoC") of Parenteral Drugs (India) Limited, the Corporate Debtor was held on Friday, 09th August, 2024 at 5:30 P.M

pdf

Parenteral Drugs (India) Ltd.

09 Aug 2024

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015(Listing Regulations) and in accordance with the requirements of sub-clause 16(g) of Para A of Part A of Schedule III of Listing Regulations, we wish to inform you that the Eighteenth meeting of Committee of Creditors ("COC"), of Parenteral Drugs (India) Limited, the Corporates Debtor is Scheduled to be held on Friday, 09th August, 2024 at 5:30 P.M.

pdf

Parenteral Drugs (India) Ltd.

13 Jul 2024

Company Update

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and in accordance with the requirements of sub-clause 16(g) of Para A of Part A of Schedule III of Listing Regulations, we would like to inform that the Seventeenth Meeting of Committee of Creditors ("CoC") of Parenteral Drugs (India) Limited, the Corporate Debtor was held on Friday, 12th July, 2024 at 05:30 P.M.

pdf

Is Parenteral Drugs (India) Ltd. worth buying?

5 Votes:

Buy 80.0%

Sell 20.0%